Korean Scutellaria Baicalensis Water Extract Inhibits Cell Cycle G1/S Transition by Suppressing Cyclin D1 Expression and Matrix-metalloproteinase-2 Activity in Human Lung Cancer Cells
Overview
Authors
Affiliations
Aim Of The Study: Scutellaria baicalensis Georgi is a widely used medicinal herb in several Asian countries including Korea. The various medicinal properties attributed to Scutellaria baicalensis include anti-bacterial, anti-viral, anti-inflammatory and anti-cancer effects. The present study investigated the cytotoxicity of Scutellaria baicalensis water extract (SBWE) on A549 non-small-cell-lung cancer cells and the A549 expression of cyclin D1, cyclin-dependent kinase 4 (CDK4) and matrix metalloproteinase-2 (MMP-2), and the effects of SBWE on cell cycle progression, especially the G1/S phase, and on cell motility.
Materials And Methods: SBWE cytotoxicity was assessed by a standard colorimetric assay utilizing 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and expression of cyclin D1 and CDK4 protein in SBWE-treated A549 cells was assessed by Western blot analysis. Flow cytometry analysis was performed to determine the effect of SBWE on A549 cell cycle progression. A549 cell MMP-2 activity was examined by zymography. Cell motility and migration was assessed by a scratch wound healing assay.
Results: SBWE was not cytotoxic. The production of Cyclin D1, CDK4 and MMP-2 activity were significantly decreased in a SBWE dose-dependent manner, with maximum inhibition occurring at SBWE concentrations of 250 μg/ml and 500 μg/ml. SBWE inhibited cell cycle progression in the G1/S phase and significantly inhibited the motility of A549 cells.
Conclusions: Cyclin D1 protein may be associated with MMP-2 activity and cell motility. Thus, SBWE promotes a strong protective effect against MMP-2 mediated metastasis and cell proliferation through the down-regulation of cyclin D1. SBWE may be a useful chemotherapeutic agent for lung cancer.
Promising leads against lung cancer from the plants in Lamiaceae family.
Rahimlouy Aghdam A, Hamedeyazdan S Bioimpacts. 2025; 15:30074.
PMID: 39963559 PMC: 11830130. DOI: 10.34172/bi.30074.
Huang H, Xie J, Wang F, Jiao S, Li X, Wang L Front Pharmacol. 2024; 15:1425157.
PMID: 39161904 PMC: 11330881. DOI: 10.3389/fphar.2024.1425157.
Chen X, Huang X, Ma Q, Kuzmic P, Zhou B, Zhang S Nat Microbiol. 2024; 9(4):1075-1088.
PMID: 38553607 PMC: 10994847. DOI: 10.1038/s41564-024-01618-9.
Ma Q, Wang Z, Chen R, Lei B, Liu B, Jiang H Phytomedicine. 2021; 95:153874.
PMID: 34923232 PMC: 8665848. DOI: 10.1016/j.phymed.2021.153874.
Bioactivity Studies of Hesperidin and XAV939.
Fazary A, Alfaifi M, Elbehairi S, Amer M, Nasr M, Abuamara T ACS Omega. 2021; 6(30):20042-20052.
PMID: 34368589 PMC: 8340382. DOI: 10.1021/acsomega.1c03080.